Kern Research, Inc

The trials here

What the 17 trials at this site are about, from their registry records.

Conditions

• Asthma6 trials
• Atopic dermatitis (eczema)5 trials
• Chronic spontaneous urticaria3 trials
• Alopecia areata2 trials
• COPD1 trial

Phase

• Phase 310 trials
• Phase 25 trials
• Phase 2/31 trial
• Phase 41 trial

Status

• Active, not recruiting6 trials
• Completed6 trials
• Recruiting5 trials

Lead sponsor

• Pfizer4 trials
• Amgen3 trials
• Upstream Bio Inc.3 trials
• Celldex Therapeutics2 trials
• Sun Pharmaceutical Industries, Inc.2 trials
• and 3 more

Running trials

• Recruiting

  A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to Severe Eczema

  NCT07783425· Phase 3· Pfizer· Source

• Recruiting

  A Study to Learn About the Study Medicine Called Tilrekimig in People With Severe Asthma

  NCT07772921· Phase 3· Pfizer· Source

• Recruiting

  A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema

  NCT07765888· Phase 3· Pfizer· Source

• Recruiting

  A Study to Learn About Ritlecitinib for the Potential Treatment of Chronic Spontaneous Urticaria in Adults.

  NCT07219615· Phase 2· Pfizer· Source

• Recruiting

  Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata

  NCT07133308· Phase 3· Sun Pharmaceutical Industries, Inc.· Source

  Contact: Head Regulatory Affairs

• Active, not recruiting

  A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPD

  NCT06981078· Phase 2· Upstream Bio Inc.· Source

• Active, not recruiting

  A Long-Term Safety and Efficacy Study of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALOUR)

  NCT06966479· Phase 2· Upstream Bio Inc.· Source

• Active, not recruiting

  Efficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/Long-acting Beta-agonist (ICS/LABA) in Comparison to ICS Dose Escalation to High Dose ICS/LABA in Adolescent and Adult Patients With Uncontrolled Asthma

  NCT06572228· Phase 4· Regeneron Pharmaceuticals· Source

• Active, not recruiting

  A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria (CSU)

  NCT06455202· Phase 3· Celldex Therapeutics· Source

• Active, not recruiting

  A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations

  NCT06052267· Phase 3· Teva Branded Pharmaceutical Products R&D LLC· Source

• Active, not recruiting

  Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata

  NCT03898479· Phase 2/3· Sun Pharmaceutical Industries, Inc.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Atopic dermatitis (eczema)2 recruiting
• Alopecia areata1 recruiting
• Asthma1 recruiting
• Chronic spontaneous urticaria1 recruiting

Closed trials

• Completed

  A Study With Self-administered Rocatinlimab in Adolescent and Adult Participants With Moderate-to-severe Atopic Dermatitis

  NCT06224192· Phase 3· Amgen· Source

• Completed

  A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALIANT)

  NCT06196879· Phase 2· Upstream Bio Inc.· Source

• Completed

  A Study Assessing Rocatinlimab on Vaccine Antibody Response in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET - VOYAGER)

  NCT05899816· Phase 3· Amgen· Source

• Completed

  A Study Assessing Rocatinlimab in Combination With Topical Corticosteroid and/or Topical Calcineurin Inhibitors in Adult Participants With Moderate-to-severe Atopic Dermatitis (AD)

  NCT05724199· Phase 3· Amgen· Source

• Completed

  A Comparison of PT027 vs PT007 Used as Needed in Participants With Asthma

  NCT05505734· Phase 3· Bond Avillion 2 Development LP· Source

• Completed

  A Phase 2 Study of CDX-0159 in Patients With Chronic Spontaneous Urticaria

  NCT05368285· Phase 2· Celldex Therapeutics· Source